Former Allergan executive David Crean will be managing director of the life sciences investment banking group of San Diego investment bank Objective Capital Partners, the bank said.
Crean was a director of corporate business development for Allergan from 2003 to 2010, working on the company’s Botox, Juvederm, Latisse, and Aczone product lines, according to his LinkedIn profile.
He was later a vice president at Aqua Pharmaceuticals before it was sold to Almirall SA.
Crean is also chief business officer for early stage diagnostic testing company Amydis Diagnostics in San Diego.
Lipkin works for our sister publication, the San Diego Business Journal, where a version of this article first appeared.
